Results 21 to 30 of about 35,220 (306)
BioMedical Engineering OnLine, 2019 For individuals affected by Type 1 diabetes (T1D), a chronic disease in which the pancreas does not produce any insulin, maintaining the blood glucose (BG) concentration as much as possible within the safety range (70–180 mg/dl) allows avoiding short ...
Martina Vettoretti, Andrea Facchinetti
doaj +1 more source
Continuous Subcutaneous Insulin Infusion [PDF]
Diabetes, 1985 Use of continuous subcutaneous insulin infusion requires continuing available care by skilled professionals, careful selection of patients, meticulous patient monitoring, and provisions for recording and reporting experiences. Insulin pumps prescribed by a physician within these guidelines are a part of treatment and should be covered by
openaire +2 more sources
Pharmacokinetics of continuous subcutaneous insulin infusion [PDF]
Diabetologia, 1983 One of the reasons for the variability of blood glucose regulation in Type 1 (insulin-dependent) diabetic patients is the huge variation in subcutaneous absorption of intermediate-acting insulin. We have investigated the variation in insulin absorption during continuous subcutaneous insulin infusion in eight such patients. The content of insulin in the
Lauritzen, Torsten +3 more
openaire +3 more sources
Continuous subcutaneous insulin infusion therapy and multiple daily insulin injections in type 1 diabetes mellitus: a comparative overview and future horizons. [PDF]
, 2015 INTRODUCTION: Continuous subcutaneous insulin infusion (CSII) therapy is currently accepted as a treatment strategy for type 1 diabetes. Transition from multiple daily injection therapy (MDI; including basal-bolus regimens) to CSII is based on ...
Hovorka, R, Mohd-Thabit, HA
core +1 more source
Insulin therapy and dietary adjustments to normalize glycemia and prevent nocturnal hypoglycemia after evening exercise in type 1 diabetes: a randomized controlled trial [PDF]
, 2014 Introduction Evening-time exercise is a frequent cause of severe hypoglycemia in type 1 diabetes, fear of which deters participation in regular exercise.
Campbell, Matthew +7 more
core +4 more sources
Continuous Subcutaneous Insulin Infusion [PDF]
Archives of Internal Medicine, 2001 A tremendous amount of data suggest that near-normal glycemic control prevents or delays complications of diabetes, which has led to a dramatic increase in continuous subcutaneous insulin infusion (CSII) or insulin pump use. In this article, the data supporting CSII in type 1 diabetes is reviewed, and the advantages and disadvantages of CSII are ...
M J, Lenhard, G D, Reeves
openaire +2 more sources
Parental evaluation of a telemonitoring service for children with Type 1 Diabetes [PDF]
, 2017 Introduction In the past years, we developed a telemonitoring service for young patients affected by Type 1 Diabetes. That service provides data to the clinical staff and offers an important tool to the parents, that are able to oversee in real time ...
Bonfanti, R +17 more
core +1 more source
Intraperitoneal insulin infusion: on the way to the artificial pancreas
Сахарный диабет, 2015 Creating an "artificial pancreas" (a "closed loop" insulin pump, with self-adjusting insulin abilities, based on real time continuous glucose monitoring data) – is one of the most actual medical challenges of modern engineering and cybernetics.Artificial
Vladimir Aleksandrovich Karpel'ev +4 more
doaj +1 more source
JMIR Diabetes, 2023 BackgroundThere is evidence in the literature that the use of sensor-augmented insulin pumps in patients with high-complexity diabetes improves metabolic control.
Miguel O'Meara +2 more
doaj +1 more source
Optimal Regulation of Blood Glucose Level in Type I Diabetes using Insulin and Glucagon
, 2019 The Glucose-Insulin-Glucagon nonlinear model [1-4] accurately describes how the body responds to exogenously supplied insulin and glucagon in patients affected by Type I diabetes.
Della Rossa, Fabio +4 more
core +4 more sources